The Effect of Charge Display on Cost of Care and Physician Practice Behaviors: A Systematic Review

Journal of General Internal Medicine

Volumn 30, Issue 6, 2015, Pages 835-842

  Goetz, Celine ^a   Rotman, Stephen R ^b   Hartoularos, George ^c   Bishop, Tara F ^d  

^a MOUNT SINAI HOSPITAL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c Massachusetts Institute of Technology Cambridge   (United States)

^d WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

charge display; costs of care; physician behavior

Indexed keywords

ARTICLE; DRUG CHOICE; GENERAL PRACTITIONER; HEALTH CARE COST; HEALTH CARE QUALITY; HOSPITAL CHARGE; HUMAN; LABORATORY TEST; MEDICAL DECISION MAKING; MEDICAL FEE; MEDICAL PRACTICE; PHYSICIAN ATTITUDE; PRESCRIPTION; RADIOLOGY; RANDOMIZED CONTROLLED TRIAL (TOPIC); STATISTICAL SIGNIFICANCE; STUDY DESIGN; SYSTEMATIC REVIEW; CLINICAL PRACTICE; COST CONTROL; DIAGNOSTIC TEST; ECONOMICS; FEE; HEALTH CARE PERSONNEL; PROCEDURES; PSYCHOLOGY;

COST SAVINGS; DIAGNOSTIC TESTS, ROUTINE; FEES AND CHARGES; HEALTH CARE COSTS; HEALTH PERSONNEL; HUMANS; PRACTICE PATTERNS, PHYSICIANS'; PRESCRIPTION FEES;

EID: 84929841860     PISSN: 08848734     EISSN: 15251497     Source Type: Journal    
DOI: 10.1007/s11606-015-3226-5     Document Type: Article

References (30)

1. McCarthy D et al. Why not the best? Results from the National Scorecard on U.S. Health System Performance, 2011. 2011, The Commonwealth Fund Commission on a High Performance Health System.
2. World Development Indicators, The World Bank. Last Updated: 06 Nov 2014. Website: http://wdi.worldbank.org/table/2.15. Accessed 28 Nov 2014.
3. Graham JD, Potyk D, Raimi E. Hospitalists’ awareness of patient charges associated with inpatient care. J Hosp Med. 2010;5(5):295–297.
4. Allan GM, Lexchin J. Physician awareness of diagnostic and nondrug therapeutic costs: a systematic review. Int J Technol Assess Health Care. 2008;24(2):158–165.
5. Kullgren JT, et al. A census of state health care price transparency websites. JAMA. 2003;309(23):2437–2438.
6. Sinaiko AD, et al. Increased price transparency in health care—challenges and potential effects. N Engl J Med. 2011;364(10):891–894.
7. Steinmetz A, et al. What does a hip replacement cost? JAMA Intern Med. 2013;173(6):432–434.
8. Bernstein JRH, et al. Availability of consumer prices from Philadelphia area hospitals for common services: electrocardiograms vs. parking. JAMA Intern Med. 2014;174(2):292–293.
9. Ivers N, Jamtvedt G, Flottorp S, Young JM, Odgaard-Jensen J, French SD, O’Brien MA, Johansen M, Grimshaw J, Oxman AD. Audit and feedback: effects on professional practice and healthcare outcomes. Cochrane Database Syst Rev. 2012;13:16.
10. Axt-Adam P, van der Wouden MA, van der Does E. Influencing behavior of physicians ordering laboratory tests: a literature study. Med Care. 1993;31(9):784–794.
11. Bates DW, et al. Does the computerized display of charges affect inpatient ancillary test utilization? Arch Intern Med. 1997;157(21):2501–2508.
12. Durand DJ, et al. Provider cost transparency alone has no impact on inpatient imaging utilization. J Am Coll Radiol. 2013;10(2):108–113.
13. Ellemdin S, Rheeder P, Soma P. Providing clinicians with information on laboratory test costs leads to reduction in hospital expenditure. S Afr Med J. 2011;101(10):746–748.
14. Feldman LS, et al. Impact of providing fee data on laboratory test ordering: a controlled clinical trial. JAMA Intern Med. 2013;173(10):903–908.
15. Hampers LC, et al. The effect of price information on test-ordering behavior and patient outcomes in a pediatric emergency department. Pediatrics. 1999;103(4 Pt 2):877–882.
16. Sachdeva RC, et al. Effects of availability of patient-related charges on practice patterns and cost containment in the pediatric intensive care unit. Crit Care Med. 1996;24(3):501–506.
17. Schilling UM. Cutting costs: the impact of price lists on the cost development at the emergency department. Eur J Emerg Med. 2010;17(6):337–339.
18. Seguin P, et al. Effects of price information on test ordering in an intensive care unit. Intensive Care Med. 2002;28(3):332–335.
19. Tierney WM, Miller ME, McDonald CJ. The effect on test ordering of informing physicians of the charges for outpatient diagnostic tests. N Engl J Med. 1990;322(21):1499–1504.
20. Horrow JC, Rosenberg H. Price stickers do not alter drug usage. Can J Anaesth. 1994;41(11):1047–1052.
21. Lin YC, Miller SR. The impact of price labeling of muscle relaxants on cost consciousness among anesthesiologists. J Clin Anesth. 1998;10(5):401–403.
22. McNitt JD, Bode ET, Nelson RE. Long-term pharmaceutical cost reduction using a data management system. Anesth Analg. 1998;87(4):837–842.
23. Cummings KM, et al. The effects of price information on physicians’ test-ordering behavior. Ordering of diagnostic tests. Med Care. 1982;20(3):293–301.
24. Rudy DW, et al. A pilot study assessing the influences of charge data and group process on diagnostic test ordering by residents. Acad Med. 2001;76(6):635–637.
25. Hart J, et al. Do drug costs affect physicians’ prescription decisions? J Intern Med. 1997;241(5):415–420.
26. Hux JE, Naylor CD. Drug prices and third party payment: do they influence medication selection? Pharmacoeconomics. 1994;5(4):343–350.
27. Salman H, et al. The effect of drug cost on hypertension treatment decision. Publ Health. 1999;133:243–246.
28. Kwok J, Jones B. Unnecessary repeat requesting of tests: an audit in a government hospital immunology laboratory. J Clin Pathol. 2005;58(5):457–462.
29. May TA, et al. Reducing unnecessary inpatient laboratory testing in a teaching hospital. Am J Clin Pathol. 2006;126(2):200–206.
30. Novich M, Gillis L, Tauber AI. The laboratory test justified. An effective means to reduce routine laboratory testing. Am J Clin Pathol. 1985;84(6):756–759.